BlueCrest Capital Management’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-350,000
Closed -$4.71M 606
2021
Q2
$4.71M Hold
350,000
0.09% 240
2021
Q1
$4.48M Buy
+350,000
New +$4.39M 0.07% 331

BlueCrest Capital Management's CMIIU Position: Q3 2021 in Review

BlueCrest Capital Management sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q3 2021, closing a stake of 350,000 shares — an estimated $4.71M sold.

BlueCrest Capital Management first reported a position in CMIIU in Q1 2021 and held it in 2 quarters. The position peaked at $4.71M in Q2 2021. 0 funds tracked by Wall St. Rank hold CMIIU as of Q3 2021.

  • BlueCrest Capital Management reported no remaining CM Life Sciences II Inc. Unit position as of Q3 2021 after selling out during the quarter.
  • BlueCrest Capital Management sold 350,000 CM Life Sciences II Inc. Unit shares in Q3 2021, an estimated $4.71M.
  • BlueCrest Capital Management first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 2 quarters.
  • BlueCrest Capital Management's CM Life Sciences II Inc. Unit position peaked at $4.71M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q3 2021.

Based on BlueCrest Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.